Drug intelligence / Profile preview

oleoylethanolamide + LipiSperse

Development stage
Unknown
Lead developer
Gencor
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Oral
01

Overview

Oleoylethanolamide + LipiSperse is a combination dietary supplement containing **oleoylethanolamide (OEA)**, a naturally occurring bioactive lipid mediator, and **LipiSperse**, a lipid-based dispersion delivery technology designed to enhance the oral bioavailability of lipophilic compounds. OEA acts as a peroxisome proliferator-activated receptor-alpha (PPAR-α) agonist, regulating food intake, satiety, lipid metabolism, and exhibiting antioxidant effects. LipiSperse improves the dispersibility and absorption of OEA in the gastrointestinal tract. This specific combination is primarily under investigation for metabolic benefits, such as modulating incretin hormone release (e.g., GLP-1 via GPR119 activation), changes in insulin, glucose, DPP-4, glucagon, and appetite-related endpoints. The combination has been studied in healthy volunteers and is being developed as a dietary supplement for potential use in weight management and metabolic health support[1][2][3][4][5][6][7].

02

Targets

GPR55 (G protein-coupled receptor 55)GPR119 (Glucose-dependent insulinotropic receptor)TRPV1 (Transient receptor potential cation channel subfamily V member 1)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on oleoylethanolamide + LipiSperse.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oleoylethanolamide + LipiSperse.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call